Column Group IV-A, LP, 10% Owner at RAPT Therapeutics, Inc. (RAPT), bought 26,550 shares at $12.50 ($324K) on 2022-05-23, disclosed to the SEC on 2022-05-25.
Open-market purchase of $324k RAPT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.50 | 338 | $4K | 1.3% |
| 2 | $12.50 | 9,898 | $124K | 38.2% |
| 3 | $12.00 | 538 | $6K | 2.0% |
| 4 | $12.00 | 15,776 | $189K | 58.5% |
| Total | $12.19 avg | 26,550 | $324K | 100% |
| Filing → |
| RAPT | BUY | 2022-05-12 | $26.7M | — | Filing → |